首页 > 市场调查报告书 > 製药

药物开发

市场调查报告书

商品编码

1563370

药物发现服务市场规模、份额、成长分析、按流程、按类型、按药物类型、按治疗领域、按最终用户、按地区 - 行业预测，2024-2031 年

Drug Discovery Services Market Size, Share, Growth Analysis, By Process, By Type, By Drug Type, By Therapeutic Area, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月29日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球药物发现服务市场规模为201亿美元，从2023年的230.7亿美元成长到2031年的696.1亿美元，预计预测期间（2024-2031年）复合年增长率为14.80%。。

全球药物发现服务市场是製药和生物技术行业快速成长的一部分，专注于开发各种疾病的新治疗方法。市场提供广泛的服务来支持复杂且资源集中的药物发现过程。药物发现包括识别和检验潜在的药物标靶、创建候选药物以及严格的安全性和有效性测试。由于这个过程成本高且耗时，製药和生物技术公司越来越依赖专业服务提供者来帮助简化和加速药物开发。这些服务提供者利用先进技术、行业专业知识和基础设施来优化药物发现。这些服务供应商提供的服务包括标靶识别和检验、命中化合物识别、先导化合物优化、药物化学以及体外和体内测试。我们也支持临床前开发和早期临床试验。随着对创新治疗方法的需求持续上升，全球药物发现服务市场在加速药物开发方面发挥关键作用。随着研发投入的增加，该市场预计未来将大幅扩大。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Laboratory Corporation of America Holdings（US）
Charles River Laboratories International, Inc.（US）
Wuxi APPTEC（China）
Pharmaron Beijing Co., Ltd.（China）
Evotec SE（Germany）
Eurofins Scientific SE（Luxembourg）
Piramal Enterprises Limited（India）
Syngene International Limited（India）
Genscript Biotech Corporation（China）
Jubilant Pharmova Limited（India）
Frontage Holdings Corporation（China）
Shanghai Medicilon Inc.（China）
Aurigene Discovery Technologies（Dr. Reddy's Laboratories）（India）
Sygnature Discovery Ltd.（UK）
Oncodesign Services（France）
Selvita SA（Poland）
Viva Biotech Holdings（China）
TCG Lifesciences Pvt Ltd.（India）
Shanghai Chempartner Co., Ltd.（China）
Domainex Ltd.（UK）
Nuvisan Pharma Holding GmbH（Germany）
Dalton Pharma Services（Canada）
Aragen Life Sciences Pvt. Ltd.（India）
Promega Corporation（US）

简介目录

Product Code: SQMIG35J2059

Global Drug Discovery Services Market size was valued at USD 20.10 billion in 2022 and is poised to grow from USD 23.07 billion in 2023 to USD 69.61 billion by 2031, growing at a CAGR of 14.80% during the forecast period (2024-2031).

The Global Drug Discovery Services Market is a rapidly growing sector within the pharmaceutical and biotechnology industries, focused on developing new treatments for various diseases. This market offers a broad range of services that assist in the complex and resource-intensive process of drug discovery. Drug discovery involves identifying and validating potential drug targets, creating drug candidates, and conducting rigorous safety and efficacy testing. Given the high cost and lengthy timelines associated with this process, pharmaceutical and biotech companies increasingly rely on specialized service providers to help streamline and accelerate drug development. These service providers utilize advanced technologies, industry expertise, and infrastructure to optimize drug discovery. Their offerings include target identification and validation, hit identification, lead optimization, medicinal chemistry, as well as in vitro and in vivo testing. They also support preclinical development and early-phase clinical trials. As the demand for innovative therapies continues to rise, the Global Drug Discovery Services Market plays a crucial role in accelerating drug development. With growing investments in research and development, this market is poised for significant expansion in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segmental Analysis

Global Drug Discovery Services Market is segmented by Process, Type, Drug Type, Therapeutic Area, and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, and Candidate Validation. Based on Type, the market is segmented into Chemistry Services, and Biology Services. Based on Drug Type, the market is segmented into Small-Molecule Drugs, and Biologics. Based on Therapeutic Area, the market is segmented into Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Immunological Disorders, Endocrine & Metabolic Disorders, Respiratory Disorders, Digestive System Diseases, Genitourinary Diseases & Women's Health, and Other Therapeutic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Drug Discovery Services Market

The increasing demand for innovative treatments for chronic diseases, along with advancements in the global healthcare sector, are expected to be key drivers of growth in the drug discovery services market. Pharmaceutical and biopharmaceutical companies continue to outsource their research and development (R&D) activities to contract research organizations (CROs), which provide specialized R&D services. These CROs are helping to optimize R&D processes through tailored engagement models, thereby improving efficiency in drug development. The growing burden of chronic diseases has also prompted governments and pharmaceutical companies to seek effective solutions and invest more heavily in clinical trials. This heightened focus on addressing chronic illnesses is driving the need for drug discovery services. As the demand for novel therapies increases, so too will the reliance on these services to support drug development efforts across the healthcare industry.

Restraints in the Global Drug Discovery Services Market

The market is expected to face two significant challenges: a shortage of skilled labor and the high failure rate of target drug molecules. The lack of trained professionals in drug discovery and development could slow down progress, as expertise is critical for advancing complex research and development processes. Additionally, the high failure rate of drug molecules in the early stages of development poses a major hurdle. Pharmaceutical companies invest millions of dollars in preclinical research to identify viable drug candidates, but when these molecules fail to meet expectations, it significantly increases the overall cost of drug development. This not only raises expenses but also adds pressure on the industry to find more efficient solutions.

Market Trends of the Global Drug Discovery Services Market

The Global Drug Discovery Services Market is witnessing several important trends that are shaping its future. One major trend is the growing reliance on outsourcing, as pharmaceutical and biotech companies increasingly turn to specialized service providers for their drug discovery needs. This approach allows companies to leverage external expertise, advanced technology, and cost-effective solutions while concentrating on their core business operations. Another key development is the rise in collaborative partnerships between pharmaceutical companies and contract research organizations (CROs). These alliances promote resource sharing, knowledge exchange, and risk-sharing, driving innovation and speeding up the drug discovery process. Technological advancements are also transforming the drug discovery services market. Cutting-edge technologies like high-throughput screening, artificial intelligence, and genomics are significantly enhancing the drug discovery process. These innovations enable quicker, more precise identification and optimization of drug candidates, leading to more efficient and successful outcomes in the development of new therapies. As a result, these trends are driving growth and fostering further evolution within the industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Technology Analysis
Pricing Analysis
Customer & Buying Criteria Analysis

Drug Discovery Services Market by Process

Market Overview
Target Selection
Target Validation
Hit-To-Lead Identification
Lead Optimization
Candidate Validation

Drug Discovery Services Market by Type

Market Overview
Chemistry Services
Biology Services

Drug Discovery Services Market by Drug Type

Market Overview
Small-Molecule Drugs
Biologics

Drug Discovery Services Market by Therapeutic Area

Market Overview
Oncology
Infectious Diseases
Cardiovascular Diseases
Neurological Diseases
Immunological Disorders
Endocrine & Metabolic Disorders
Respiratory Disorders
Digestive System Diseases
Genitourinary Diseases & Women's Health
Other Therapeutic Areas

Drug Discovery Services Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
- Tier 1 Companies
- Tier 2 Companies
- Tier 3 Companies
Academic Institutes
Other End Users

Drug Discovery Services Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi APPTEC (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron Beijing Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evotec SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Enterprises Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syngene International Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Pharmova Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Holdings Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Medicilon Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurigene Discovery Technologies (Dr. Reddy's Laboratories) (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sygnature Discovery Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oncodesign Services (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Selvita S.A. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viva Biotech Holdings (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TCG Lifesciences Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Chempartner Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Domainex Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvisan Pharma Holding GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dalton Pharma Services (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aragen Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments